Tscan Non Operating Income Net Other from 2010 to 2025

TCRX Stock  USD 1.35  0.10  6.90%   
Tscan Therapeutics Non Operating Income Net Other yearly trend continues to be fairly stable with very little volatility. Non Operating Income Net Other will likely drop to about 332 K in 2025. During the period from 2010 to 2025, Tscan Therapeutics Non Operating Income Net Other regression line of annual values had r-squared of  0.31 and arithmetic mean of  407,219. View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2010-12-31
Previous Quarter
373.5 K
Current Value
332 K
Quarterly Volatility
22.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tscan Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tscan Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 8.8 M, Interest Income of 12.7 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 86.63, Dividend Yield of 0.0 or PTB Ratio of 1.48. Tscan financial statements analysis is a perfect complement when working with Tscan Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tscan Therapeutics Correlation against competitors.
For more information on how to buy Tscan Stock please use our How to Invest in Tscan Therapeutics guide.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tscan Stock Analysis

When running Tscan Therapeutics' price analysis, check to measure Tscan Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tscan Therapeutics is operating at the current time. Most of Tscan Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tscan Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tscan Therapeutics' price. Additionally, you may evaluate how the addition of Tscan Therapeutics to your portfolios can decrease your overall portfolio volatility.